No Data
The entire pharmaceutical sector has surged sharply; what happened?
On Monday, all AH Stocks in the pharmaceutical Sector surged, with innovative drugs performing the strongest. The Yinhua CSI Innovative Drugs Industry ETF collectively rose sharply, driven by three main factors: the relaxation of collective procurement, overseas license authorizations, and improvement in Earnings Reports that will reshape the Industry landscape.
The opening dominates the screen! The strongest new main line in the second quarter.
Funds are quickly being amassed.
The "wind" has reached the pharmaceutical stocks, and the Sector is experiencing a surge in limit-up prices! What are the Bullish catalysts?
Catalysts from news, warming performance, and the advantages of valuation may become the main factors boosting the rise of pharmaceutical stocks.
Duory Pharmaceutical (301075.SZ): Expected loss of 53 million to -69 million yuan in 2024.
On January 23, Ge Long Hui reported that Duo Rui Pharmaceutical (301075.SZ) expects a loss of 53 million yuan to -69 million yuan in 2024, with a non-recurring loss of 56 million yuan to -73 million yuan. (1) Due to the impact of policies such as pharmaceutical price linkage, the price of the company’s core product, sodium acetate Ringer's injection, has significantly declined. (2) The Phase II clinical trial of the Traditional Chinese Medicine class 1 new drug Yi Fei Ji Sheng granules has been completed with patient enrollment, leading to increased related costs. (3) The initial production costs of some intermediate products are relatively high, resulting in a negative gross margin and the provision for inventory impairment. (4) SiChuan Duo Rui Pharmaceutical Co., Ltd.
Dorui Pharmaceuticals: 2024 Annual Results Forecast
Duorui Medicine (301075.SZ): Currently, all workshops built by Xinchengda have been put into production, and the production operation situation is normal.
On January 10, Gelonghui reported that Duori Pharmaceutical (301075.SZ) stated on the investor interaction platform that all the workshops of Xinchengda have been put into production, and the production and Operation situation is normal. For specific details, please pay attention to the company's announcements and regular reports.
